期刊文献+

肠毒素C2蛋白C,N末端对其活性的影响 被引量:1

Effects of the Amino Terminal and the Carboxyl Terminal on Staphylococcal enterotoxin C2
原文传递
导出
摘要 目的:分析金黄色葡萄球菌肠毒素C2(SEC2)中N,C末端对其超抗原活性和可溶性表达能力的影响。方法:应用基因工程技术对SEC2的N,C末端进行部分删除,获得三种突变蛋白,并对其进行体外超抗原活性和可溶性表达能力的比较。结果:对SEC2的N,C末端的删除都在一定程度上影响其超抗原活性和可溶性表达能力,其中,N末端的两个删除突变体的超抗原活性分别降低40%和48%,而删除C末端则使其可溶性表达水平下降到野生型的20%左右。结论:SEC2蛋白分子的N末端对其超抗原活性起主要作用,C末端对其可溶性表达具有显著影响,而完整的SEC2分子对于其发挥最大生物学活性是必要的。 Objective :The purpose of this study is to analyze the effects of the amino terminal and the carboxyl terminal of Staphylococcal enterotoxin C2 (SEC2). on its superantigen activity and soluble expression. Method:In this study,the amino terminal and the carboxyl ter- minal of SEC2 were partly deleted by gene engineering method to construct three truncated mutants. The superantigen activity and the soluble expression of the three mutants were evaluated compare with wild - type SEC2. Result: The deletions of both the amino terminal and the carboxyl terminal of SEC2 resulted in decreased superantigen activity and decreased solubility. The superantigen activity of two amino terminal truncated mutants showed 40% and 48% reduction compared with native SEC2, respectively. And the deletion of carboxyl terminal significantly decreased the soluble expression ability to about 20% of native SEC2. Conclusion:The amino terminal of SEC2 is important for superantigen activity, and the carboxyl terminal is important for the solubility of SEC2. The intact structure of SEC2 is essential to its effective biological activity.
出处 《生物技术》 CAS CSCD 北大核心 2012年第1期34-38,共5页 Biotechnology
基金 国家科技重大专项重大新药创制项目(2012ZX09102301-013)资助
关键词 金黄色葡萄球菌肠毒素C2 删除突变体 超抗原活性 可溶性表达 Staphylococcal enterotoxin C2 deletion mutant superantigen activity soluble expression
  • 相关文献

参考文献15

二级参考文献42

  • 1刘民,马华,李柏青.MTT法检测小鼠淋巴细胞增殖性反应探讨[J].中国实验动物学杂志,1999,9(3):146-149. 被引量:63
  • 2徐明恺,张成刚,周亚凤,张先恩.金黄色葡萄球菌肠毒素C2的基因克隆、表达及其生物学活性[J].生物化学与生物物理进展,2005,32(3):275-281. 被引量:13
  • 3李龄蒜,王杰,马元良,等.肝癌介入治疗[M]∥临床介入治疗学.2版.广州广东科技出版社,2001:268-269.
  • 4冯国生,王豫平,韦波,王丰,刘惕生,秦志强,李俊杰,黄英华,黄建辉,冯穗.免疫因子与经动脉化疗联合介入治疗晚期肺癌[J].中国肿瘤临床,1997,24(6):448-451. 被引量:7
  • 5Nishiyama Y,Karle S,Planque S,et al.Antibodies to the superantigenic site of HIV-1 gpl20:hydrolytic and binding activities of the light chain subunit[J].Molecular Immunology,2007,44(10):2707-2718.
  • 6Nam J,Shin D,Rew Y,et al.Alanine scan of[L-Dap2]ramoplanin A2 aglycon:assessment of the importance of each residue[J].Journal of the American Chemical Society,2007,129 (28):8747-8755.
  • 7White J,Herman A,Pullen AM,et al.The V beta-specific superantigen staphylococcal enterotoxin B:stimulation of mature T cells and clonal deletion in neonatal mice[J].Ce11,1989,56(1):27-35.
  • 8Holtfreter S,Grumann D,Schmudde M,et al.Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates[J].Journal of Clinical Microbiology,2007,48 (8):2669-2680.
  • 9Thomas D,Chou S,Dauwalder O,et al.Diversity in Staphylococcus aureus enterotoxins[J].Chemical Immunology and Allergy,2007,93 (1):24-41.
  • 10Bhatia A,Zahoor S.Staphylococcus aureus enterotoxins:A review[J].J Clin Diag Res,2007,95(3):188-197.

共引文献24

同被引文献13

  • 1徐明恺,张成刚,周亚凤,张先恩.金黄色葡萄球菌肠毒素C2的基因克隆、表达及其生物学活性[J].生物化学与生物物理进展,2005,32(3):275-281. 被引量:13
  • 2Bohach GA,Fast DJ,Nelson RD. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses[J].Critical Reviews in Microbiology,1990.251-272.
  • 3Wang X G,Zhang H W,Xu M K. Biolofical analysis of the deletion mutants of Staphylococcal enterotoxin C2[J].Applied Microbiology and Biotechnology,2009,(06):1077-1084.
  • 4Amanda J Broanahan,Patrick M,Schlievert. Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome[J].FEBS Journal,2011.4649-4667.
  • 5Anastassios C Papageorgiou1,K Ravi Acharyal,Robert Shapiro. Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site[J].Structures,1995.769-779.
  • 6Wang X G,Xu M K,Zhang H W. Enhancement of superantigen activity and antitumor response of staphylococcal enterotoxin C2 by site-directed mutagenesis Cancer Immunology[J].Immunotherapy,2009,(05):677-686.
  • 7Hoffmann M L,Jablonski L M,Crum K K. Predictions of T-cell receptor-and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1[J].Infection and Immunity,1994.3396-3407.
  • 8Turner T N,Smith C L. Residues 20,22,and 26 determine the subtype specificities of staphylococcal enterotoxins C1 and C2[J].Infection and Immunity,1992,(02):694-697.
  • 9Bohach G A,Schlievert P M. Conservation of the biologically active portions of staphylococcal enterotoxins C1 and C2[J].Infection and Immunity,1989,(07):2249-2252.
  • 10John D Fraser,Thomas Proft. The bacterial superantigen and superantigen-like proteins[J].Immunological,2008.226-243.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部